Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.1% Topical Ciclosporin A for 12-weeks in Dry Eye Disease
NCT06898853Recruiting
- Sponsor
- University of New South Wales
- Start
- Jun 2025
- Primary completion
- Dec 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of cyclosporine in dry eye disease (DED) (2 arms), sponsored by University of New South Wales. Primary endpoints: Corneal epithelial immune cell density at 12 weeks and Conjunctival immune cell density at 12 weeks. Started Jun 2025; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06898853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06898853.